Uterine Tonus Assessment by Midwives versus Patient self-assessment in the active management of the third stage of labor (UTAMP): study protocol for a randomized controlled trial

Joyce L Browne, Nelson K R Damale, Tessa M Raams, Eva L Van der Linden, Ernest T Maya, Roseline Doe, Marcus J Rijken, Richard Adanu, Diederick E Grobbee, Arie Franx, Kerstin Klipstein-Grobusch, Joyce L Browne, Nelson K R Damale, Tessa M Raams, Eva L Van der Linden, Ernest T Maya, Roseline Doe, Marcus J Rijken, Richard Adanu, Diederick E Grobbee, Arie Franx, Kerstin Klipstein-Grobusch

Abstract

Background: Postpartum hemorrhage (PPH) is the leading cause of maternal mortality worldwide and accounts for one third of maternal deaths in low-income and middle-income countries. PPH can be prevented by active management of the third stage of labor (AMTSL), a series of steps recommended by the World Health Organization to be performed by skilled birth attendants (SBAs). Task shifting in the AMTSL step of uterotonic drugs administration to community health workers, traditional birth attendants and self-administration has been investigated as a strategy to increase access to quality obstetric care considering persistent SBA and facility-based delivery shortages. The aim of this study is to assess task shifting in the final step of AMTSL and compare uterine tonus assessment by a SBA to self-assessment.

Methods and design: The study is an individual-level two-arm non-inferiority randomized controlled trial (RCT). A total of 800 women will be recruited in Korle Bu Teaching Hospital in Accra, Ghana. Adult women in labor at term with an expected vaginal delivery who received antenatal instructions for self-assessment of uterine tonus will be eligible for inclusion. Women with an increased risk for PPH will be excluded. Women will be randomized to uterine tone assessment by a skilled birth attendant (midwife) or uterine tone self-assessment (with the safety back-up of a midwife present in case of PPH or uterine atony). Postpartum blood loss will be measured through weighing of disposable mats. The main study endpoints are PPH (≥500 ml blood loss), severe PPH (≥1000 ml blood loss), mean blood loss, and routine maternal and neonatal outcomes. Participants and caregivers will not be blinded given the nature of the intervention.

Discussion: A reduction of PPH-related maternal mortality requires full implementation of AMTSL. Task shifting of uterine tone assessment may contribute to increased AMTSL implementation in (clinical) settings where SBAs capacity is constrained.

Trial registration: Clinicaltrials.gov: NCT02223806 , registration August 2014.

Pactr: PACTR201402000736158 , registration July 2014. University of Ghana, Medical School Ethical and Protocol Review Committee: MS-Et/M.8-P4.1/2014-2015.

References

    1. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Heal. 2014;2:e323–33. doi: 10.1016/S2214-109X(14)70227-X.
    1. World Health Organization . WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization Press; 2012.
    1. McLintock C, James AH. Obstetric hemorrhage. J Thromb Haemost. 2011;9:1441–51. doi: 10.1111/j.1538-7836.2011.04398.x.
    1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–74. doi: 10.1016/S0140-6736(06)68397-9.
    1. WHO, UNICEF, UNFPA the World Bank and the United Nations Population Division. Trends in maternal mortality: 1990 to 2013. Geneva; 2014.
    1. Zakariah AY, Alexander S, van Roosmalen J, Buekens P, Kwawukume EY, Frimpong P. Reproductive age mortality survey (RAMOS) in Accra, Ghana. Reprod Health. 2009;6:7. doi: 10.1186/1742-4755-6-7.
    1. Ghana Health Services. Annual Reproductive and Child Health, Report 2008. 2008.
    1. Ghana Health Services. Annual Reproductive and Child Health, Report 2009. 2009.
    1. Ghana Health Services. Annual Reproductive and Child Health, Report 2011. 2011.
    1. Ghana Health Services. Annual Reproductive and Child Health, Report 2012. 2012.
    1. Stanton C. Use of active management of the third stage of labour in seven developing countries. Bull World Health Organ. 2009;87:207–15. doi: 10.2471/BLT.08.052597.
    1. Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189–200. doi: 10.1016/S0140-6736(06)69380-X.
    1. WHO . WHO recommendations on prevention and treatment of postpartum haemorrhage – highlights and key messages from new 2012 global recommendations. Geneva: World Health Organization; 2014.
    1. International Federation of Gynecology and Obstetrics, The International Confederation of Midwives Joint statement: management of the third stage of labour to prevent post-partum haemorrhage. J Midwifery Womens Health. 2004;49:76–7. doi: 10.1111/j.1542-2011.2004.tb04420.x.
    1. Sheldon WR, Blum J, Vogel JP, Souza JP, Gülmezoglu AM, Winikoff B. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl):5–13. doi: 10.1111/1471-0528.12636.
    1. Begley C, Gyte G, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2011
    1. Prata N, Bell S, Holston M, Quaiyum MA. Is attendant at delivery associated with the use of interventions to prevent postpartum hemorrhage at home births? The case of Bangladesh. BMC Pregnancy Childbirth. 2014;14:24. doi: 10.1186/1471-2393-14-24.
    1. World Health Organization. WHO recommendations: optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting. Geneva; 2012.
    1. Prata N, Bell S, Weidert K. Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Womens Health. 2013;5:737–52. doi: 10.2147/IJWH.S51661.
    1. Miller S, Lester F, Hensleigh P. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. J Midwifery Womens Health. 2004;49:283–92. doi: 10.1016/j.jmwh.2004.04.001.
    1. Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG. 2011;118:353–61. doi: 10.1111/j.1471-0528.2010.02807.x.
    1. Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane database Syst Rev. 2012;8:CD000494.
    1. Gülmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689–95. doi: 10.1016/S0140-6736(01)05835-4.
    1. Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane database Syst Rev. 2012;2:CD009336.
    1. Prata N, Passano P, Bell S, Rowen T, Potts M. New hope: community-based misoprostol use to prevent postpartum haemorrhage. Health Policy Plan. 2013;28:339–46. doi: 10.1093/heapol/czs068.
    1. Geller S, Carnahan L, Akosah E, Asare G, Agyemang R, Dickson R, et al. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana. BJOG. 2014;121(3):319-25. .
    1. Weeks A. The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG. 2015;122(2):202-10.
    1. Stanton CK, Newton S, Mullany LC, Cofie P, Tawiah Agyemang C, Adiibokah E, et al. Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial. PLoS Med. 2013;10:e1001524. doi: 10.1371/journal.pmed.1001524.
    1. Sealed Envelope Ltd. 2012. Power calculator for binary outcome non-inferiority trial. [Online] Available from: . Accessed 21 September 2015.
    1. Schorn MN. Measurement of blood loss: review of the literature. J Midwifery Womens Health. 2010;55:20–7. doi: 10.1016/j.jmwh.2009.02.014.

Source: PubMed

3
订阅